Clinical Trial Update: A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

View source ↗

Summary

A completed study from Janssen examining biomarkers in lung and blood samples from participants with suspected non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Carcinoma, Non-Small-Cell Lung | Status: COMPLETED